Born 1955. Member of the board of directors since 2017. Member of Commercialization Committee.
Professional background: Hans Maier is a former biopharma executive. Hans has held global executive positions in Schering AG and Bayer AG and served on the Executive Committee of Bayer-Schering Pharma AG after the merger of both companies. After his industry career Hans co-founded BGM Associates GmbH, a specialized Healthcare and Life Science Strategy and Transaction Advisory and served as one of its Managing Partners until the end of 2025.
Education: Ph.D. in Economics and Diploma in Political Science from Freie Universität Berlin, Germany and Executive Program, Stanford University Graduate School of Business.
Other ongoing assignments: Chairman and Chief Executive Officer German Heart Center Foundation, Vice-Chairman Supervisory Board German Heart Center at Charité (Deutsches Herzzentrum der Charité), Member Supervisory Board Charité Universitätsmedizin Berlin. Hans is a Visiting Professor of International Strategic Management at Berlin School of Economics and Law and Chairman of the Board of Trustees of the Fraunhofer Mevis Institute for Digital Medicine.
Holdings in Ascelia: View holdings
Independence: Independent in relation to the company and its management and in relation to major shareholders.